speb/financial-data huggingface dataset:
EMR balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 20282000000.00
EMR balance_sheet (annual, 2025-09-30) — Tangible Book Value: -7369000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -7369000000.00
EMR income_statement (annual, 2025-09-30) — Tax Effect Of Unusual Items: -104754000.00
EMR income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -23718592.96
EMR income_statement (annual, 2025-09-30) — Tax Provision: 696000000.00
EMR income_statement (quarterly, 2025-09-30) — Tax Provision: 160000000.00
EMR income_statement (annual, 2025-09-30) — Tax Rate For Calcs: 0.24
EMR income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.20
EMR balance_sheet (annual, 2025-09-30) — Total Assets: 41964000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Total Assets: 41964000000.00
EMR balance_sheet (annual, 2025-09-30) — Total Capitalization: 28601000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 28601000000.00
EMR balance_sheet (annual, 2025-09-30) — Total Debt: 13759000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Total Debt: 13759000000.00
EMR balance_sheet (annual, 2025-09-30) — Total Equity Gross Minority Interest: 20298000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 20298000000.00
EMR income_statement (annual, 2025-09-30) — Total Expenses: 14484000000.00
EMR income_statement (quarterly, 2025-09-30) — Total Expenses: 3873000000.00
EMR balance_sheet (annual, 2025-09-30) — Total Liabilities Net Minority Interest: 21666000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 21666000000.00
EMR balance_sheet (annual, 2025-09-30) — Total Non Current Assets: 33381000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 33381000000.00
EMR balance_sheet (annual, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 11869000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 11869000000.00
EMR balance_sheet (annual, 2025-09-30) — Total Tax Payable: 130000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 130000000.00
EMR income_statement (annual, 2025-09-30) — Total Unusual Items: -442000000.00
EMR income_statement (quarterly, 2025-09-30) — Total Unusual Items: -118000000.00
EMR income_statement (annual, 2025-09-30) — Total Unusual Items Excluding Goodwill: -442000000.00
EMR income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -118000000.00
EMR balance_sheet (annual, 2025-09-30) — Treasury Shares Number: 390600000.00
EMR balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 390600000.00
EMR balance_sheet (annual, 2025-09-30) — Treasury Stock: 20062000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 20062000000.00
EMR balance_sheet (annual, 2025-09-30) — Working Capital: -1214000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Working Capital: -1214000000.00
EMR income_statement (annual, 2025-09-30) — Write Off: 0.00
EMR income_statement (quarterly, 2025-12-31) — +Operating Expense: 1447000000.00
EMR income_statement (quarterly, 2025-12-31) — +Total Revenue: 4346000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1339000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 2972000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -3594000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 16000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -124000000.00
EMR income_statement (quarterly, 2025-12-31) — Amortization: 205000000.00
EMR cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 275000000.00
EMR cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 275000000.00
EMR income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 205000000.00
EMR income_statement (quarterly, 2025-12-31) — Basic Average Shares: 561800000.00
EMR income_statement (quarterly, 2025-12-31) — Basic EPS: 1.08
EMR cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1544000000.00
EMR cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -97000000.00
EMR cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -97000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 652000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Capital Stock: 477000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1748000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1748000000.00
EMR cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -312000000.00
EMR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -364000000.00
EMR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -125000000.00
EMR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 699000000.00
EMR cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -33000000.00
EMR cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -250000000.00
EMR cash_flow (quarterly, 2025-12-31) — Change In Inventory: -141000000.00
EMR cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -52000000.00
EMR cash_flow (quarterly, 2025-12-31) — Change In Payable: -33000000.00
EMR cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -283000000.00
EMR cash_flow (quarterly, 2025-12-31) — Change In Receivables: 119000000.00
EMR cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -357000000.00
EMR cash_flow (quarterly, 2025-12-31) — Changes In Cash: 210000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Common Stock: 477000000.00
EMR cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -312000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 20277000000.00
EMR cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -250000000.00
EMR income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2035000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1383000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Current Assets: 8843000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 139000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Current Debt: 5693000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 5832000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1088000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1088000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 10520000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Current Provisions: 85000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 1247000000.00
EMR cash_flow (quarterly, 2025-12-31) — Depreciation: 84000000.00
EMR cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 359000000.00
EMR income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 205000000.00
EMR cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 359000000.00
EMR income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 205000000.00
EMR income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 564100000.00
EMR income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.07
EMR income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 605000000.00
EMR income_statement (quarterly, 2025-12-31) — EBIT: 891000000.00
EMR income_statement (quarterly, 2025-12-31) — EBITDA: 1250000000.00
EMR cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -6000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 454000000.00
EMR cash_flow (quarterly, 2025-12-31) — End Cash Position: 1748000000.00
EMR cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -364000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Finished Goods: 563000000.00
EMR cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 602000000.00
EMR income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -13000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -828000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Goodwill: 18182000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 27387000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 3096000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Gross PPE: 7101000000.00
EMR income_statement (quarterly, 2025-12-31) — Gross Profit: 2311000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 193000000.00
EMR income_statement (quarterly, 2025-12-31) — Interest Expense: 116000000.00
EMR income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 116000000.00
EMR income_statement (quarterly, 2025-12-31) — Interest Income: 26000000.00
EMR income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 26000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Inventory: 2353000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Invested Capital: 33545000000.00
EMR cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -125000000.00
EMR cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 3473000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 513000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 7575000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 8088000000.00
EMR cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -587000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Minority Interest: 15000000.00
EMR income_statement (quarterly, 2025-12-31) — Minority Interests: -1000000.00
EMR cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
EMR cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -250000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Net Debt: 11520000000.00
EMR income_statement (quarterly, 2025-12-31) — Net Income: 605000000.00
EMR income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 605000000.00
EMR income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 606000000.00
EMR income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 605000000.00
EMR income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 605000000.00
EMR cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 606000000.00
EMR income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 606000000.00
EMR income_statement (quarterly, 2025-12-31) — Net Interest Income: -90000000.00
EMR cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 302000000.00
EMR cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -587000000.00
EMR income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -90000000.00
EMR cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -104000000.00
EMR cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -28000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Net PPE: 3507000000.00
EMR cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 889000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -7110000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 660000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 75000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1792000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 75000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1792000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 454000000.00
EMR income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1273000000.00
EMR income_statement (quarterly, 2025-12-31) — Normalized Income: 622940000.00
EMR cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 699000000.00
EMR income_statement (quarterly, 2025-12-31) — Operating Income: 864000000.00
EMR income_statement (quarterly, 2025-12-31) — Operating Revenue: 4346000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 562000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1770000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 5693000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 139000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -828000000.00
EMR income_statement (quarterly, 2025-12-31) — Other Income Expense: 1000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 9205000000.00
EMR cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 36000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 220000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 793000000.00
EMR income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 24000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Other Properties: 7101000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Payables: 1532000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2915000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 461000000.00
EMR income_statement (quarterly, 2025-12-31) — Pretax Income: 775000000.00
EMR cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
EMR balance_sheet (quarterly, 2025-12-31) — Raw Materials: 1790000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Receivables: 2972000000.00
EMR income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1881000000.00
EMR income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 359000000.00
EMR cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -3171000000.00
EMR cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -250000000.00
EMR income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 10000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 40871000000.00
EMR income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1242000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Share Issued: 953400000.00
EMR cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 3473000000.00
EMR cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -2584000000.00
EMR income_statement (quarterly, 2025-12-31) — Special Income Charges: -10000000.00
EMR cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 55000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 20277000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -7110000000.00
EMR income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -5060000.00
EMR income_statement (quarterly, 2025-12-31) — Tax Provision: 169000000.00
EMR income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.22
EMR balance_sheet (quarterly, 2025-12-31) — Total Assets: 41939000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 27852000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Total Debt: 13920000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 20292000000.00
EMR income_statement (quarterly, 2025-12-31) — Total Expenses: 3482000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 21647000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 33096000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 11127000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 193000000.00
EMR income_statement (quarterly, 2025-12-31) — Total Unusual Items: -23000000.00
EMR income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -23000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 391400000.00
EMR balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 20259000000.00
EMR balance_sheet (quarterly, 2025-12-31) — Working Capital: -1677000000.00
EMR income_statement (quarterly, 2026-03-31) — +Operating Expense: 1521000000.00
EMR income_statement (quarterly, 2026-03-31) — +Total Revenue: 4562000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1468000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3158000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -3620000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 64000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -125000000.00
EMR income_statement (quarterly, 2026-03-31) — Amortization: 205000000.00
EMR cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 282000000.00
EMR cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 282000000.00
EMR income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 205000000.00
EMR income_statement (quarterly, 2026-03-31) — Basic Average Shares: 560100000.00
EMR income_statement (quarterly, 2026-03-31) — Basic EPS: 1.10
EMR cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1748000000.00
EMR cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -85000000.00
EMR cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -85000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 698000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Capital Stock: 477000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1791000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1791000000.00
EMR cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -312000000.00
EMR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -649000000.00
EMR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -81000000.00
EMR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 779000000.00
EMR cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 119000000.00
EMR cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 3000000.00
EMR cash_flow (quarterly, 2026-03-31) — Change In Inventory: -110000000.00
EMR cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -74000000.00
EMR cash_flow (quarterly, 2026-03-31) — Change In Payable: 119000000.00
EMR cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 122000000.00
EMR cash_flow (quarterly, 2026-03-31) — Change In Receivables: -194000000.00
EMR cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -256000000.00
EMR cash_flow (quarterly, 2026-03-31) — Changes In Cash: 49000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Common Stock: 477000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 20303000000.00
EMR cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -292000000.00
EMR income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2140000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1343000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Current Assets: 9251000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 144000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Current Debt: 5804000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5948000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 1175000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 1175000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 10654000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Current Provisions: 79000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Defined Pension Benefit: 1266000000.00
EMR cash_flow (quarterly, 2026-03-31) — Depreciation: 87000000.00
EMR cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 369000000.00
EMR income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 205000000.00
EMR cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 369000000.00
EMR income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 205000000.00
EMR income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 563000000.00
EMR income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.10
EMR income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 618000000.00
EMR income_statement (quarterly, 2026-03-31) — EBIT: 903000000.00
EMR income_statement (quarterly, 2026-03-31) — EBITDA: 1272000000.00
EMR cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -6000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 452000000.00
EMR cash_flow (quarterly, 2026-03-31) — End Cash Position: 1791000000.00
EMR cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -649000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Finished Goods: 596000000.00
EMR cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 694000000.00
EMR income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -19000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -861000000.00
EMR income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1316000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Goodwill: 18153000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 27107000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 3283000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Gross PPE: 7147000000.00
EMR income_statement (quarterly, 2026-03-31) — Gross Profit: 2422000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 57000000.00
EMR income_statement (quarterly, 2026-03-31) — Interest Expense: 110000000.00
EMR income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 110000000.00
EMR income_statement (quarterly, 2026-03-31) — Interest Income: 26000000.00
EMR income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 26000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Inventory: 2452000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Invested Capital: 33662000000.00
EMR cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -81000000.00
EMR cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 3001000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 554000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 7555000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 8109000000.00
EMR cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
EMR balance_sheet (quarterly, 2026-03-31) — Minority Interest: 16000000.00
EMR income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
EMR cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
EMR cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -292000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Net Debt: 11568000000.00
EMR income_statement (quarterly, 2026-03-31) — Net Income: 618000000.00
EMR income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 618000000.00
EMR income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 618000000.00
EMR income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 618000000.00
EMR income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 618000000.00
EMR cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 618000000.00
EMR income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 618000000.00
EMR income_statement (quarterly, 2026-03-31) — Net Interest Income: -84000000.00
EMR cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -26000000.00
EMR cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
EMR income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -84000000.00
EMR cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -19000000.00
EMR cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 4000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Net PPE: 3527000000.00
EMR cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -26000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -6804000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 640000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 81000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1745000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 81000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1745000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 452000000.00
EMR income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1337000000.00
EMR income_statement (quarterly, 2026-03-31) — Normalized Income: 668700000.00
EMR cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 779000000.00
EMR income_statement (quarterly, 2026-03-31) — Operating Income: 901000000.00
EMR income_statement (quarterly, 2026-03-31) — Operating Revenue: 4562000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 560100000.00
EMR balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1850000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 5804000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -861000000.00
EMR income_statement (quarterly, 2026-03-31) — Other Gand A: 1316000000.00
EMR income_statement (quarterly, 2026-03-31) — Other Income Expense: -24000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 8954000000.00
EMR cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -10000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 216000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 809000000.00
EMR income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 41000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Other Properties: 7147000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Payables: 1525000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 2868000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 584000000.00
EMR income_statement (quarterly, 2026-03-31) — Pretax Income: 793000000.00
EMR cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
EMR balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1856000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Receivables: 3158000000.00
EMR income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1976000000.00
EMR income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 369000000.00
EMR cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -3027000000.00
EMR cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -292000000.00
EMR income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 46000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 41176000000.00
EMR income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1316000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Share Issued: 953400000.00
EMR cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 3001000000.00
EMR cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -3027000000.00
EMR income_statement (quarterly, 2026-03-31) — Special Income Charges: -46000000.00
EMR cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 58000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 20303000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -6804000000.00
EMR income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -14300000.00
EMR income_statement (quarterly, 2026-03-31) — Tax Provision: 175000000.00
EMR income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
EMR balance_sheet (quarterly, 2026-03-31) — Total Assets: 42088000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 27858000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Total Debt: 14057000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 20319000000.00
EMR income_statement (quarterly, 2026-03-31) — Total Expenses: 3661000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 21769000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 32837000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 11115000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 57000000.00
EMR income_statement (quarterly, 2026-03-31) — Total Unusual Items: -65000000.00
EMR income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -65000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 393300000.00
EMR balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 20553000000.00
EMR balance_sheet (quarterly, 2026-03-31) — Working Capital: -1403000000.00
EMR.AX cash_flow (annual, 2021-06-30) — Capital Expenditure Reported: -92500000.00
EMR.AX balance_sheet (annual, 2021-06-30) — Derivative Product Liabilities: 24540000.00
EMR.AX cash_flow (annual, 2021-06-30) — Net Other Investing Changes: -3133000.00
EMR.AX balance_sheet (annual, 2021-06-30) — Other Current Assets: 144000.00
EMR.AX balance_sheet (annual, 2021-06-30) — Other Current Liabilities: 27869000.00
EMR.AX balance_sheet (annual, 2021-06-30) — Other Short Term Investments: 204000.00
EMR.AX cash_flow (annual, 2021-06-30) — Sale Of Investment: 135000.00
EMR.AX income_statement (annual, 2022-06-30) — +Operating Expense: 47003000.00
EMR.AX income_statement (annual, 2022-06-30) — +Total Revenue: 206469000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 14761000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -16463000.00
EMR.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 537152000.00
EMR.AX income_statement (annual, 2022-06-30) — Basic EPS: 0.08
EMR.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 22761000.00
EMR.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -48995000.00
EMR.AX cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -43017000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 286156000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 43047000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 44835000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Cash Equivalents: 70000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 42977000.00
EMR.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: -42778000.00
EMR.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -28469000.00
EMR.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: 88958000.00
EMR.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 17711000.00
EMR.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -114588000.00
EMR.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 206569000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Common Stock: 286156000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 244644000.00
EMR.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 468000.00
EMR.AX cash_flow (annual, 2022-06-30) — Common Stock Payments: -4000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Construction In Progress: 352000.00
EMR.AX income_statement (annual, 2022-06-30) — Cost Of Revenue: 69540000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Current Assets: 96167000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Current Deferred Liabilities: 14753000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Current Deferred Taxes Liabilities: 14753000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 91684000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Current Provisions: 15571000.00
EMR.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 31066000.00
EMR.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 31066000.00
EMR.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 31066000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Derivative Product Liabilities: 18876000.00
EMR.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 541360382.00
EMR.AX income_statement (annual, 2022-06-30) — Diluted EPS: 0.08
EMR.AX income_statement (annual, 2022-06-30) — EBIT: 79831000.00
EMR.AX income_statement (annual, 2022-06-30) — EBITDA: 110897000.00
EMR.AX cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: 2575000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Employee Benefits: 262000.00
EMR.AX cash_flow (annual, 2022-06-30) — End Cash Position: 43047000.00
EMR.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: -42778000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Foreign Currency Translation Adjustments: 1155000.00
EMR.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: 39963000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 5857000.00
EMR.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 6531000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 337956000.00
EMR.AX income_statement (annual, 2022-06-30) — Gross Profit: 136929000.00
EMR.AX cash_flow (annual, 2022-06-30) — Income Tax Paid Supplemental Data: 3041000.00
EMR.AX income_statement (annual, 2022-06-30) — Interest Expense: 17123000.00
EMR.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 17123000.00
EMR.AX income_statement (annual, 2022-06-30) — Interest Income: 63000.00
EMR.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 63000.00
EMR.AX cash_flow (annual, 2022-06-30) — Interest Paid Cff: -21167000.00
EMR.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 18000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Inventory: 32870000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 244644000.00
EMR.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -28469000.00
EMR.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 468000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Land And Improvements: 39623000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Leases: 65000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Loans Receivable: 2500000.00
EMR.AX cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -15878000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Long Term Provisions: 23553000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 64108000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Minority Interest: 4479000.00
EMR.AX cash_flow (annual, 2022-06-30) — Net Business Purchase And Sale: 3022000.00
EMR.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 464000.00
EMR.AX income_statement (annual, 2022-06-30) — Net Income: 45366000.00
EMR.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: 45366000.00
EMR.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: 45366000.00
EMR.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: 45366000.00
EMR.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: 45366000.00
EMR.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: 45366000.00
EMR.AX income_statement (annual, 2022-06-30) — Net Interest Income: -19947000.00
EMR.AX cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: -740000.00
EMR.AX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -15878000.00
EMR.AX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -15878000.00
EMR.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -19947000.00
EMR.AX cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -6197000.00
EMR.AX cash_flow (annual, 2022-06-30) — Net Other Investing Changes: 18244000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Net PPE: 321493000.00
EMR.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -5978000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 244644000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 262000.00
EMR.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: 110897000.00
EMR.AX income_statement (annual, 2022-06-30) — Normalized Income: 45366000.00
EMR.AX income_statement (annual, 2022-06-30) — Operating Income: 89926000.00
EMR.AX income_statement (annual, 2022-06-30) — Operating Revenue: 206469000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 593350983.00
EMR.AX cash_flow (annual, 2022-06-30) — Other Cash Paymentsfrom Operating Activities: -5983000.00
EMR.AX cash_flow (annual, 2022-06-30) — Other Cash Receiptsfrom Operating Activities: 2000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Other Current Assets: 182000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Other Current Liabilities: 35496000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 4702000.00
EMR.AX income_statement (annual, 2022-06-30) — Other Gand A: 596000.00
EMR.AX income_statement (annual, 2022-06-30) — Other Income Expense: -7271000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Other Inventories: 32870000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Other Non Current Assets: 25142000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Other Non Current Liabilities: 59304000.00
EMR.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: -7271000.00
EMR.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 9406000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Other Payable: 11096000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Other Properties: 124042000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 14334000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Other Short Term Investments: 1788000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Payables: 25857000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 25857000.00
EMR.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -108605000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 7000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 1446000.00
EMR.AX income_statement (annual, 2022-06-30) — Pretax Income: 62708000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Properties: 109766000.00
EMR.AX cash_flow (annual, 2022-06-30) — Purchase Of Investment: -740000.00
EMR.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -5978000.00
EMR.AX cash_flow (annual, 2022-06-30) — Receiptsfrom Customers: 206567000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Receivables: 16834000.00
EMR.AX income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 69540000.00
EMR.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 31066000.00
EMR.AX income_statement (annual, 2022-06-30) — Rent And Landing Fees: 284000.00
EMR.AX cash_flow (annual, 2022-06-30) — Repayment Of Debt: -15878000.00
EMR.AX cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: -4000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -47369000.00
EMR.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 5651000.00
EMR.AX cash_flow (annual, 2022-06-30) — Sale Of Business: 3022000.00
EMR.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 6531000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Share Issued: 593350983.00
EMR.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 244644000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 244644000.00
EMR.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
EMR.AX income_statement (annual, 2022-06-30) — Tax Provision: 17342000.00
EMR.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.28
EMR.AX cash_flow (annual, 2022-06-30) — Taxes Refund Paid Direct: -3041000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Total Assets: 442802000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 244644000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 249123000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 193679000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 346635000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 101995000.00
EMR.AX income_statement (annual, 2022-06-30) — Total Other Finance Cost: 2887000.00
EMR.AX balance_sheet (annual, 2022-06-30) — Working Capital: 4483000.00
EMR.AX income_statement (annual, 2023-06-30) — +Operating Expense: 76355000.00
EMR.AX income_statement (annual, 2023-06-30) — +Total Revenue: 297666000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 13309000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -35339000.00
EMR.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 593772000.00
EMR.AX income_statement (annual, 2023-06-30) — Basic EPS: 0.11
EMR.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 43047000.00
EMR.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -8606000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 286769000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 70963000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 71465000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Cash Equivalents: 70000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 70893000.00
EMR.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: -55942000.00
EMR.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -15058000.00
EMR.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: 95473000.00
EMR.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 24473000.00
EMR.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -188766000.00
EMR.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: 303914000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Common Stock: 286769000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 320123000.00
EMR.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 4646000.00
EMR.AX cash_flow (annual, 2023-06-30) — Common Stock Payments: -37000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Construction In Progress: 1000000.00
EMR.AX income_statement (annual, 2023-06-30) — Cost Of Revenue: 115941000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Current Assets: 127679000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Current Deferred Liabilities: 17236000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Current Deferred Taxes Liabilities: 17236000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 98132000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Current Provisions: 19820000.00
EMR.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 42445000.00
EMR.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 42445000.00
EMR.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 42445000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Derivative Product Liabilities: 11753000.00
EMR.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 593772000.00
EMR.AX income_statement (annual, 2023-06-30) — Diluted EPS: 0.11
EMR.AX income_statement (annual, 2023-06-30) — EBIT: 92394000.00
EMR.AX income_statement (annual, 2023-06-30) — EBITDA: 134839000.00
EMR.AX cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: 3443000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Employee Benefits: 351000.00
EMR.AX cash_flow (annual, 2023-06-30) — End Cash Position: 70963000.00
EMR.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: -55942000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Foreign Currency Translation Adjustments: 3438000.00
EMR.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: 86867000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 10270000.00
EMR.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 8518000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 324018000.00
EMR.AX income_statement (annual, 2023-06-30) — Gross Profit: 181725000.00
EMR.AX cash_flow (annual, 2023-06-30) — Income Tax Paid Supplemental Data: 21152000.00
EMR.AX income_statement (annual, 2023-06-30) — Interest Expense: 21479000.00
EMR.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 21479000.00
EMR.AX income_statement (annual, 2023-06-30) — Interest Income: 1810000.00
EMR.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 1810000.00
EMR.AX cash_flow (annual, 2023-06-30) — Interest Paid Cff: -26641000.00
EMR.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 1477000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Inventory: 38141000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 320123000.00
EMR.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -15058000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Investments And Advances: 3318000.00
EMR.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 4646000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Land And Improvements: 29674000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Leases: 588000.00
EMR.AX cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -19227000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Long Term Provisions: 14872000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 84201000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Minority Interest: 3859000.00
EMR.AX cash_flow (annual, 2023-06-30) — Net Business Purchase And Sale: -3792000.00
EMR.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 4609000.00
EMR.AX income_statement (annual, 2023-06-30) — Net Income: 66281000.00
EMR.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: 66281000.00
EMR.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: 66281000.00
EMR.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: 66281000.00
EMR.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: 66281000.00
EMR.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: 66281000.00
EMR.AX income_statement (annual, 2023-06-30) — Net Interest Income: -22589000.00